Pyrls vs PneumoRecs VaxAdvisor使用状況と統計
Pyrls is a drug reference for the most practical information focused on design and simplicity.
Pyrls includes the fast information that you need for top drugs:
• Naming, indications, and pharmacology
• Counseling points and clinical pearls related to place in therapy, safety and monitoring for each medication
• Reference tables, figures, charts, and more
In-App Purchase Information and Terms of Service Information
Payment will be charged to your iTunes Account at confirmation of purchase. Accounts will be charged for renewal within 24-hours prior to the end of the current period. Subscriptions will automatically renew unless canceled within 24-hours before the end of the current period. Manage your subscriptions in your iPhone Account Settings after purchase. Introductory pricing or discounts, if available, will only apply for the initial introductory period of the subscription.
For information regarding the acceptable use of this app, see our Terms of Service at https://pyrls.com/terms-of-service.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
This is the PneumoRecs VaxAdvisor App created by the Centers for Disease Control and Prevention (CDC) in collaboration with the Georgia Tech Research Institute. PneumoRecs VaxAdvisor provides patient-specific pneumococcal vaccination guidance consistent with the pneumococcal vaccination recommendations of the Advisory Committee on Immunization Practices. Vaccination providers enter a patient’s age and respond to prompts about the patient’s pneumococcal vaccination history and underlying medical conditions. The app then displays patient-specific pneumococcal vaccination recommendations consistent with the recommended U.S. immunization schedule.
- Apple App ストア
- 無料
- 医学
ストアランキング
- -
Pyrls対PneumoRecs VaxAdvisorランキング比較
と過去28日間の Pyrls ランキング傾向を比較 PneumoRecs VaxAdvisor
PneumoRecs VaxAdvisor#183
ランキング
Pyrls 対 PneumoRecs VaxAdvisor 国の比較によるランキング
と過去28日間の Pyrls ランキング傾向を比較 PneumoRecs VaxAdvisor
業界別 ウェブサイトカテゴリー
ご利用可能なデータがありません
医学
無料トライアルで任意のサイトと比較する


3月 13, 2025